Jun 30, 2025

Featuring perspectives from Dr Joyce F Liu, Dr David M O’Malley, Dr Ritu Salani, Dr Alessandro D Santin and Dr Shannon N Westin, moderated by Dr Westin, including the following topics:

• Introduction (0:00)
• Up-Front Treatment for Advanced Ovarian Cancer (OC) — Dr Liu (2:00)
• Current Management of Relapsed/Refractory...

Jun 27, 2025

Featuring perspectives from Ms Ilene Galinsky, Dr Michael J Mauro, Dr Neil P Shah and Dr Sara M Tinsley-Vance, including the following topics:

• Introduction: Chronic Myeloid Leukemia (CML) as a Model for Targeted Treatment (0:00)
• Biology of CML; Role of First- and Second-Generation Tyrosine Kinase Inhibitors (TKIs) as...

Jun 25, 2025

Featuring perspectives from Dr Neeraj Agarwal, Dr Andrew J Armstrong, Dr Himisha Beltran, Dr Rana R McKay and Dr Fred Saad, moderated by Dr McKay, including the following topics:

• Introduction (0:00)
• Evolving Management of Nonmetastatic Hormone-Sensitive Prostate Cancer (HSPC) — Dr Saad (2:12)
• Current Treatment for...

Jun 24, 2025

Featuring an interview with Dr Patrick Y Wen, including the following topics:

• Glioma classification (0:00)
• Efficacy and safety of vorasidenib in the management of IDH-mutant gliomas (4:50)
• Case: A woman in her early 30s with a Grade 2 astrocytoma and an IDH R132H mutation and residual disease...

Jun 23, 2025

Featuring a slide presentation and related discussion from Dr Patrick Y Wen, including the following topics:

• Classification and pathologic diagnosis of gliomas (0:00)
• Role of IDH inhibitors in the management of low-grade gliomas (6:37)
• Ongoing trials and remaining questions in the management of IDH-mutant gliomas...